Ajanta Pharma Ltd.
Snapshot View

1276.35 +5.55 ▲0.4%

12 August 2022, 04:01:00 PM
Volume: 1,485

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.ajantapharma.com
Market Cap 16,352.61 Cr.
Enterprise Value(EV) 16,143.37 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 55.69 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 22.92 Trailing Twelve Months Ending 2022-06
Industry PE 32.02 Trailing Twelve Months Ending 2022-06
Book Value / Share 269.04 Trailing Twelve Months Ending 2022-06
Price to Book Value 4.74 Calculated using Price: 1,276.35
Dividend Yield 0.50 Period Ending 2022-03
No. of Shares Subscribed 12.81 Cr. 128,125,155 Shares
FaceValue 2
Company Profile
Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages. Its business includes Branded Generics in emerging markets of Asia and Africa, Generics in the developed markets of USA and Institution sales. Emerging markets are the major contributors in company's branded generic business where it is present across Asia and Africa. It has designed customised basket of products for each of these markets and serve wide range of therapeutic segments like Anti-Biotic, Anti-Malarial, Anti-Diabetic, Cardiology, Gynecology, Orthopedics, Pediatric, Respiratory & General Health products.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.44%
1 Week
-0.19%
1 Month
+7.24%
3 Month
+12.31%
6 Month
-7.36%
1 Year
-14.82%
2 Year
+17.67%
5 Year
+56.32%
10 Year
+1810.42%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 47.47 43.24 40.93 36.77 26.00 18.07 19.32 23.38 22.77
Return on Capital Employed (%) 54.52 56.43 51.59 45.72 34.49 23.84 27.44 32.20 29.37
Return on Assets (%) 28.05 29.57 31.66 30.69 22.06 14.52 14.44 17.03 16.79

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 393 593 841 1,191 1,568 2,041 2,245 2,599 2,996 3,264
Non Curr. Liab. 102 81 56 29 9 39 162 228 275 279
Curr. Liab. 222 275 250 260 247 346 498 746 839 838
Minority Int.
Equity & Liab. 718 949 1,146 1,479 1,823 2,426 2,906 3,572 4,109 4,381
Non Curr. Assets 349 429 513 716 973 1,202 1,605 1,791 1,891 1,926
Curr. Assets 369 520 633 763 851 1,224 1,301 1,781 2,218 2,455
Misc. Exp. not W/O
Total Assets 718 949 1,146 1,479 1,823 2,426 2,906 3,572 4,109 4,381

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 1,208 1,474 1,734 1,983 2,126 2,055 2,588 2,890 3,341 3,544
Other Income 14 17 21 24 24 21 92 26 116 116
Total Income 1,222 1,490 1,755 2,007 2,150 2,076 2,680 2,916 3,457 3,660
Total Expenditure -840 -968 -1,147 -1,296 -1,467 -1,489 -1,905 -1,891 -2,412 -2,613
PBIDT 382 522 608 711 683 588 776 1,025 1,045 1,047
Interest -9 -6 -5 -1 0 -1 -12 -8 -10 -10
Depreciation -44 -52 -44 -61 -60 -72 -96 -116 -125 -126
Taxation -96 -146 -143 -141 -154 -127 -196 -246 -197 -197
Exceptional Items -8 -4
PAT 234 310 416 507 469 387 468 654 713 714
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 234 310 416 507 469 387 468 654 713 714
Adjusted EPS 18 23 31 38 36 30 36 50 56 55

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 234 212 279 326 609 281 375 457 576 562
Cash Fr. Inv. -104 -188 -158 -209 -383 -256 -223 -224 -282 -74
Cash Fr. Finan. -104 -20 -105 -117 -202 0 -147 -129 -318 -460
Net Change 26 4 16 0 24 25 4 104 -24 28
Cash & Cash Eqvt 34 39 54 41 66 91 95 199 178 205

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 70.51 70.51 70.34 70.34 70.34 70.34 70.34 70.48 70.48
Public 29.49 29.49 29.66 29.66 29.66 29.66 29.66 29.52 29.52
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 16.15 16.06 15.17 15.49 14.95 13.73 15.37 16.60 20.09

Announcements View Details >>

Sat, 06 Aug 2022
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on August 05 2022 for Aayush Agrawal trustee Aayush Agrawal Trust
Thu, 04 Aug 2022
Proceeding Of 43Rd Annual General Meeting
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we enclose herewith summary of proceedings of 43rd Annual General Meeting of the Company held on 4th August 2022 through Video- conference/Other Audio-Visual Means.
Thu, 04 Aug 2022
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Pursuant to Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we submit herewith the following:a. Details of voting results through remote e-voting and at the AGM on each of the resolutions set out in the notice; b. Consolidated Scrutinizers Report dated 4th August 2022 on remote e-voting and at the AGM.

Technical Scans View Details >>

Fri, 12 Aug 2022
High Increase 1 Month High Increase 1 Month
High Increase 3 Months High Increase 3 Months
Closing Near 20 SMA Closing Near 20 SMA
William %R Bullish William %R Bullish
ROC Trending Up ROC Trending Up

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,167.25 913.45 -0.8%
Divi's Laboratories Ltd. 98,918.90 3,726.20 -5.6%
Cipla Ltd. 82,906.37 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. 70,920.35 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. 62,010.73 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. 51,917.53 1,534.00 -0.1%
Piramal Enterprises Ltd. 45,855.65 1,921.35 +0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.35 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 33.43 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-06 33.32 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.69 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.15 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.82 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-06 24.38 1,921.35 +0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.37 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8.44 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-06 3.86 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.50 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.43 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.12 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,921.35 +0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,921.35 +0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,921.35 +0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,921.35 +0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,921.35 +0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,921.35 +0.8%

FAQ's On Ajanta Pharma Ltd.

Can I Buy Ajanta Pharma Shares now?

What is the Share Price of Ajanta Pharma?

What is the Relative Strength Index (RSI) Value of Ajanta Pharma?

What is the Market Capital (MCAP) of Ajanta Pharma?

What are the key metrics to analyse Ajanta Pharma?

What is the Price Performance of Ajanta Pharma?